Antimicrobial Activity of Ceftolozane–Tazobactam Tested against Contemporary (2012–2016) Enterobacteriaceae and Pseudomonas aeruginosa from ICU vs. non-ICU Isolates Collected in US Medical Centers

BACKGROUND: Ceftolozane-tazobactam (C-T) is a combination of a novel antipseudomonal cephalosporin and a well-described β-lactamase inhibitor. C-T was approved by the United States (US) Food and Drug Administration in 2014 for complicated urinary tract infections, including acute pyelonephritis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortridge, Dee, Duncan, Leonard R, Pfaller, Michael A, Flamm, Robert K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631266/
http://dx.doi.org/10.1093/ofid/ofx163.894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631266/
http://dx.doi.org/10.1093/ofid/ofx163.894

Ejemplares similares